Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide

Journal of Pediatric Gastroenterology and Nutrition

Volumn 36, Issue 5, 2003, Pages 639-643

  Oliva Hemker, Maria M ^a,b   Loeb, David M ^a   Abraham, Susan C ^a   Lederman, Howard M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Brady 320 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MERCAPTOPURINE; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENTEROPATHY; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; ENTEROPATHY; FEMALE; HUMAN; INFANT; NEUTROPENIA; PANCREATITIS; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION; BLOOD; DIARRHEA; DUODENUM; IMMUNOLOGY; PATHOLOGY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; DIARRHEA; DUODENUM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINAL DISEASES; REMISSION INDUCTION;

EID: 0141613186     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200305000-00010     Document Type: Article

References (23)

1. Mirakian R, Richardson A, Milla PJ, et al. Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. BMJ 1986;293:1132-6.
2. Walker-Smith JA, Unsworth DJ, Hutchins P, et al. Autoantibodies against gut epithelium in a child with small-intestinal enteropathy. Lancet 1982;1:566-7.
3. Seidman EG, Lacaille F, Russo P, et al. Successful treatment of autoimmune enteropathy with cyclosporine. J Pediatr 1990;117:929-32.
4. Bousvaros A, Leichtner AM, Book L, et al. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology 1996;111:237-43.
5. Brodsky RA, Petri M, Smith BD, et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998;129:1031-5.
6. Brodsky RA. High-dose cyclophosphamide for aplastic anemia and autoimmunity. Curr Opin Oncol 2002;14:143-6.
7. Nousari HC, Brodsky RA, Jones RJ, et al. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol 1999;40:750-4.
8. Corazza GR, Biagi F, Volta U, et al. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997;350:106-9.
9. Catassi C, Fabiani E, Spagnuolo MI, et al. Working Group of the Italian society of Pediatric Gastroenterology and Hepatology (SIGEP). Severe and protracted diarrhea: results of the 3-year SIGEP multicenter survey. J Pediatr Gastroenterol Nutr 1999;29:63-8.
10. Goulet OJ, Brousse N, Canioni D, et al. Syndrome of intractable diarrhea with persistent villous atrophy in early childhood: a clinicopathologic survey of 47 cases. J Pediatr Gastroenterol Nutr 1998;26:151-61.
11. Cutz E, Sherman PM, Davidson GP. Enteropathies associated with protracted diarrhea of infancy: clinicopathologic features, cellular and molecular mechanisms. Pediatr Pathol Lab Med 1997;17:335-67.
12. Murch SH, Fertleman CR, Rodrigues C, et al. Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: the contribution of T cells to the mucosal lesion. J Pediatr Gastroenterol Nutr 1999;28:393-9.
13. Hill SM, Milla PJ, Bottazzo GF, et al. Autoimmune enteropathy and colitis: is there evidence of a generalized autoimmune gut disorder? Gut 1991;32:36-42.
14. Russo PA, Brochu P, Seidman EG, et al. Autoimmune enteropathy. Pediatr Dev Pathol 1999;2:65-71.
15. McCarthy DM, Katz SI, Gazze L, et al. Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific-anti- epithelial cell antibody. J Immunol 1978;120:932-8.
16. Savilahti E, Pelkonen P, Holmberg C, et al. Fatal unresponsive villous atrophy of the jejunum, connective tissue disease and diabetes in a girl with intestinal epithelial cell antibody. Acta Paediatr Scand 1995;74:472-6.
17. Colletti RB, Guillot AP, Rosen S, et al. Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr Gastroenterol Nutr 1991;118:858-64.
18. Speck B, Cornu P, Jeannet M, et al. Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol 1976;4:131-7.
19. Baran DT, Griner PF, Klemperer MR. Recovery from aplastic anemia after treatment with cyclophosphamide. N Engl J Med 1976;295:1522-3.
20. Brodsky RA, Fuller AK, Ratner LE, et al. Elimination of alloantibodies by immunoablative high-dose cyclophosphamide. Transplantation 2001;71:482-4.
21. Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000;356:701-7.
22. McDiarmid SV, Wallace P, Vargas J, et al. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 1995;20:291-9.
23. Brodsky RA, Sensenbrenner LL, Smith D, et al. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 2001;135:477-83.